The Trump administration has confirmed that it will discontinue its $45 million annual contribution to Namibia’s HIV/AIDS response program. This decision marks the end of a two-decade-long financial commitment. According to a joint statement released by the U.S. and Namibian governments, the current funding structure will be phased out over the coming years, with the final payment scheduled for the 2027 fiscal year.

Officials characterized the move as a transition rather than an abrupt withdrawal. The statement indicated that the relationship between the two nations regarding public health will move toward a "technical cooperation model." This shift suggests that while direct financial aid is ending, the U.S. intends to continue providing expertise or advisory support to the Namibian health sector.

While the announcement frames the change as a strategic evolution of the partnership, the cessation of $45 million in annual funding represents a significant reduction in direct U.S. health assistance to the country. The joint statement emphasizes that this transition is a planned evolution of the long-standing bilateral relationship, though it does not provide specific details on how the Namibian government plans to bridge the resulting funding gap in its HIV treatment and prevention infrastructure. The program has been a cornerstone of U.S.-Namibia health cooperation for twenty years, and the transition timeline provides a window for the Namibian government to adjust its domestic health budget or seek alternative international funding sources before the final payment is issued in 2027.